1921
Volume 103, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Brazil is, at the time of writing, the global epicenter of COVID-19, but information on risk factors for hospitalization and mortality in the country is still limited. Demographic and clinical data of COVID-19 patients until June 11th, 2020 were retrieved from the State Health Secretariat of Espírito Santo, Brazil. Potential risk factors for COVID-19 hospitalization and death were analyzed by univariate and multivariable logistic regression models. A total of 10,713 COVID-19 patients were included in this study; 81.0% were younger than 60 years, 55.2% were female, 89.2% were not hospitalized, 32.9% had at least one comorbidity, and 7.7% died. The most common symptoms on admission were cough (67.7%) and fever (62.6%); 7.1% of the patients were asymptomatic. Cardiovascular diseases (23.7%) and diabetes (10.3%) were the two most common chronic diseases. Multivariate logistic regression analysis identified an association of all explanatory variables, except for cough and diarrhea, with hospitalization. Older age (odds ratio [OR] = 3.95, < 0.001) and shortness of breath (OR = 3.55, < 0.001) were associated with increase of odds to COVID-19 death in hospitalized patients. Our study provided evidence that older age, male gender, Asian, indigenous or unknown race, comorbidities (smoking, kidney disease, obesity, pulmonary disease, diabetes, and cardiovascular disease), as well as fever and shortness of breath increased the risk of hospitalization. For death outcome in hospitalized patients, only older age and shortness of breath increased the risk.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.20-0483
2020-07-16
2020-09-28
Loading full text...

Full text loading...

/deliver/fulltext/14761645/103/3/tpmd200483.html?itemId=/content/journals/10.4269/ajtmh.20-0483&mimeType=html&fmt=ahah

References

  1. World Health Organization, 2020. Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV). Available at: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). Accessed May 1, 2020.
    [Google Scholar]
  2. World Health Organization, 2020. Coronavirus Disease 2019 (COVID-19) Situation Report–162. Available at: https://www.who.int/docs/default-source/coronaviruse/20200630-covid-19-sitrep-162.pdf?sfvrsn=e00a5466_2. Accessed July 1, 2020.
    [Google Scholar]
  3. Croda J, Oliveira WK, Frutuoso RL, Mandetta LH, Baia-da-Silva DC, Brito-Sousa JD, Monteiro WM, Lacerda MVG, 2020. COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases. Rev Soc Bras Med Trop 53: e20200167.
    [Google Scholar]
  4. Ministry of Health of Brazil, 2020. Painel Coronavírus Brazil. Available at: https://covid.saude.gov.br/. Accessed July 1, 2020.
    [Google Scholar]
  5. Wu Z, McGoogan JM, 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323: 12391242.
    [Google Scholar]
  6. Guan W et al., 2020. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382: 17081720.
    [Google Scholar]
  7. Wang D et al., 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323: 10611069.
    [Google Scholar]
  8. Huang R et al., 2020. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center study. PLoS Negl Trop Dis 14: e0008280.
    [Google Scholar]
  9. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y, 2020. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 94: 9195.
    [Google Scholar]
  10. Vigo D, Psych L, Thornicroft G, Gureje O, 2020. The differential outcomes of coronavirus disease 2019 in low- and middle-income countries vs high-income countries. JAMA Psychiatry. Available at: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2767252.
    [Google Scholar]
  11. Gonçalves L, Dias MC, 2020. Discussões bioéticas sobre a alocação de recursos durante a pandemia da COVID-19 no Brazil. DIVERSITATES Int J 12: 1837.
    [Google Scholar]
  12. OKBR, 2020. Transparência COVID-19. Available at: https://transparenciacovid19.ok.org.br/. Accessed May 1, 2020.
    [Google Scholar]
  13. Raupp FM, Pinho JAG, 2020. Precisamos evoluir em transparência? Uma análise dos estados Brasileiros na divulgação de informações sobre a COVID-19. Gestão Soc 14: 37253739.
    [Google Scholar]
  14. Espírito Santo State Health Secretariat, 2020. Painel COVID-19 - Estado Do Espírito Santo. Available at: https://coronavirus.es.gov.br/painel-covid-19-es. Accessed June 11, 2020.
    [Google Scholar]
  15. Espírito Santo State Health Secretariat, 2020. NOTA TÉCNICA COVID-19 No 29/2020 - GEVS/SESA/ES Definição de Casos Operacionais e Critérios de Coleta. Available at: https://coronavirus.es.gov.br/Media/Coronavirus/NotasTecnicas/NOTA%20T%C3%89CNICA%20COVID.19%20N.%2029.20%20Defini%C3%A7%C3%A3o%20de%20caso%20e%20crit%C3%A9rios%20de%20coleta.pdf. Accessed June 20, 2020.
    [Google Scholar]
  16. R Core Team, 2020. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
    [Google Scholar]
  17. Chen N et al., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395: 507513.
    [Google Scholar]
  18. Chen R et al., 2020. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest 158: 97105.
    [Google Scholar]
  19. Li X et al., 2020. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 146: 110118.
    [Google Scholar]
  20. Ruan Q, Yang K, Wang W, Jiang L, Song J, 2020. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46: 846848.
    [Google Scholar]
  21. Zhang J et al., 2020. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China. Clin Microbiol Infect 26: 767772.
    [Google Scholar]
  22. Garg s et al., 2020. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019–COVID-NET, 14 states, March 1–30, 2020. MMWR Morb Mortal Wkly Rep 69: 458464.
    [Google Scholar]
  23. Petrilli CM et al., 2020. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York city: prospective cohort study. BMJ 369: m1966.
    [Google Scholar]
  24. Verdecchia P, Cavallini C, Spanevello A, Angeli F, 2020. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 76: 1420.
    [Google Scholar]
  25. Tetro JA, 2020. Is COVID-19 receiving ADE from other coronaviruses? Microbes Infect 22: 7273.
    [Google Scholar]
  26. Peron JPS, Nakaya H, 2020. Susceptibility of the elderly to SARS-CoV-2 infection: ACE-2 overexpression, shedding, and antibody-dependent enhancement (ADE). Clinics (Sao Paulo) 75: e1912.
    [Google Scholar]
  27. Wolff JL, Starfield B, Anderson G, 2020. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162: 22692276.
    [Google Scholar]
  28. Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H, 2020. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203: 631637.
    [Google Scholar]
  29. Sama IE et al., 2020. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J 41: 18101817.
    [Google Scholar]
  30. Du Y et al., 2020. Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med 201: 13721379.
    [Google Scholar]
  31. Chen T et al., 2020. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368: m1091.
    [Google Scholar]
  32. Jaillon S, Berthenet K, Garlanda C, 2019. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol 56: 308321.
    [Google Scholar]
  33. Wu C et al., 2020. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 180: 111.
    [Google Scholar]
  34. Killerby ME et al., 2020. Characteristics associated with hospitalization among patients with COVID-19–metropolitan Atlanta, Georgia, March–April 2020. MMWR Morb Mortal Wkly Rep 69: 790794.
    [Google Scholar]
  35. Cai G, Cui X, Zhu X, Zhou J, 2020. A Hint on the COVID-19 Risk: Population Disparities in Gene Expression of Three Receptors of SARS-CoV. Available at: https://www.preprints.org/manuscript/202002.0408/v1. Accessed May 28, 2020.
    [Google Scholar]
  36. Yang X et al., 2020. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8: 475481.
    [Google Scholar]
  37. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, The Northwell COVID-19 Research Consortium, 2020. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 323: 20522059.
    [Google Scholar]
  38. Dondorp AM, Hayat M, Aryal D, Beane A, Schultz MJ, 2020. Respiratory support in novel coronavirus disease (COVID-19) patients, with a focus on resource-limited settings. Am J Trop Med Hyg 102: 11911197.
    [Google Scholar]
  39. Du RH et al., 2020. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J 55: 2000524.
    [Google Scholar]
  40. Henry BM, Lippi G, 2020. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol 28: 12.
    [Google Scholar]
  41. Farsalinos K, Barbouni A, Niaura R, 2020. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med 9: 18.
    [Google Scholar]
  42. Han L, Ran J, Mak YW, Suen LKP, Lee PH, Peiris JSM, Yang L, 2020. Smoking and influenza-associated morbidity and mortality: a systematic review and meta-analysis, Epidemiology 30: 405417.
    [Google Scholar]
  43. Schmidt FM et al., 2015. Inflammatory cytokines in general and central obesity and modulating effects of physical aactivity. PLoS One 10: e0121971.
    [Google Scholar]
  44. Caër C, Rouault C, Le Roy T, Poitou C, Aron-Wisnewsky J, Torcivia A, Bichet JC, Clément K, Guerre-Millo M, André S, 2017. Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue. Sci Rep 7: 111.
    [Google Scholar]
  45. GBD 2015 Obesity Collaborators, 2017. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377: 1327.
    [Google Scholar]
  46. Honce R, Schultz-Cherry S, 2019. Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol 10: 1071.
    [Google Scholar]
  47. Kass DA, Duggal P, Cingolani O, 2020. Obesity could shift severe COVID-19 disease to younger ages. Lancet 395: 15441545.
    [Google Scholar]
  48. Henry BM, Oliveira MHS, Benoit S, Plebani M, Lippi G, 2020. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 58: 10211028.
    [Google Scholar]
  49. Ranganathan P, Pramesh C, Aggarwal R, 2017. Common pitfalls in statistical analysis: logistic regression. Perspect Clin Res 8: 148151.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.20-0483
Loading
/content/journals/10.4269/ajtmh.20-0483
Loading

Data & Media loading...

  • Received : 14 May 2020
  • Accepted : 08 Jul 2020
  • Published online : 16 Jul 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error